NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 363 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $233,945 | -52.1% | 3,890 | -41.6% | 0.17% | -54.9% |
Q4 2022 | $488,511 | -3.5% | 6,660 | 0.0% | 0.38% | -9.5% |
Q3 2022 | $506,000 | +12.7% | 6,660 | +3.1% | 0.42% | +15.7% |
Q2 2022 | $449,000 | -14.1% | 6,460 | +2.4% | 0.36% | +5.2% |
Q1 2022 | $523,000 | +21.1% | 6,310 | +9.6% | 0.34% | +28.4% |
Q4 2021 | $432,000 | -35.4% | 5,755 | 0.0% | 0.27% | -39.8% |
Q3 2021 | $669,000 | -49.4% | 5,755 | -3.4% | 0.44% | -48.7% |
Q2 2021 | $1,321,000 | – | 5,955 | – | 0.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |